Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Cancer Congress 2018

About the Conference

About the Conference

Conference Series Ltd invites all participants across the world to join 18th World Congress on Cancer Biology and Radiology which is going to be held during  July 18-19,  2018 Atlanta, USA.

Cancer-2018 is a trending event which brings together efficient international academic scientists, young researchers, and students making the congress a perfect platform to share experience, gain and evaluate emerging technologies in Cancer Treatment and Radiology across the globe. Initiation of cross-border co-operations between scientists and institutions will be also facilitated. The Main theme of the Conference is “Furtherance and Innovations in Cancer Care and Radiology”. This conference provides three days of great opportunity to discuss on recent approaches and advancements for development of new techniques for global health

ConferenceSeries Ltd organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Target Audience:

Radiology and Oncology Students, Cancer Researcher, Scientists, Radiology and Oncology Researchers, Radiology and Oncology Faculty, Medical Colleges, Scientists, Doctors, Professors, Oncology Lecturers, Researchers, Pharmaceutical Industries, Healthcare Industries, Directors of Association and Societies, Cancer and Radiology Training Institutes, Staff development educators.

2017 Highlights:

300+ Participation (70 Industry: 30 Academia)

5+ Keynote Speakers

50+ Plenary Speakers

20+ Exhibitors

14 Innovative Educational Sessions

5+ Workshops

B2B Meetings



Track 1 Cancer:

Track 2 Cancer and Cell biology:

Track 3 Organ Specific Cancer:

Track 4 Leukemia:

Track  5 Lymphoma:

Track 6 Cancer Immunology:

Track 7 Cancer genomics:

Track 8 Cancer Screening:

Track 9 Cancer biomarkers:

Track 10 Oncology & Hematology:

Track 11 Advancing Immunotherapy:

Track 12 Cancer and Stem Cells:

Track 13 Pharmacology of Cancer:

Track 14 Microbiology and Cancer:

Track  15Cancer Drugs and  Treatment:

Track 16 Medical Imaging:

Track 17 Trends in Radiology:

Track 18 Medical Imaging Software:

Track 19 Carcinogenesis and Mutagenesis:

Market Analysis

Key Agenda:

An increasing amount of population in the world has resulted in growth of cancer. It is being estimated that, cancer has affected more than 40% of the population globally. Considering the curing and aspects related to it the main agenda is to analyse the marketing potential of latest advancements, trends and innovations related to cancer treatment and techniques being used. Many organizations and associations have been putting effort to increase the productivity of various segments of cancer treatment Products.

Global Cancer Drugs Market, by Region:

  • North America: The leading cancer drugs and surgical market is North America  covering mainly U.S. and Canada.
  • Europe: Second largest lead of cancer drugs devices mainly Germany, France, U.K., Italy, Spain and Rest of Europe (RoE).
  • Asia-Pacific (APAC): Including major countries like Japan, China, India, Rest of Asia-Pacific (Ro APAC).
  • Latin America: Including Brazil, Mexico, Rest of Latin America (RoLA)
  • Regions of Middle East and Africa.

Fig: Distributaion of types of cancer

Why Atlanta?

Around 17% of the Atlanta population of 40 years of age or older have been affected by cancer so that that even more than 15.4 million. They have been diagnosed with cancer. According to Novartis healthcare in 2015 nearly 4 million cancer surgeries were performed each year. Due to growing demands in America followed by Europe and Asia, have biggest share of the international medicine and surgical devices market.  Moreover there arises a vast need to spread awareness regarding pre-surgical and post-surgical effects to patients.

Why to Attend?

Conference on Cancer Biology and Radiology is a package of useful and latest advancements by professional researchers, doctors and Pharmacists specialized in cancer research and treatment tp provide better life. Conference is aimed at exploring and putting light on various ventures like advancements in clinical field of cancer biology and radiology for improvement of previous techniques and introduction to novel therapeutics, advancements in cancer biology and radiology.

Glimpse of Cancer drug Market and surgical instruments:

Cancer Drugs market is segmented as North America, Europe, Asia Pacific, Latin America and Middle East & Africa.  America dominated the ophthalmology cataract surgery devices market due to large geriatric population. Market saturation and slowing economy pose as barrier to the U.S. ophthalmology cataract surgery devices market's growth. However, Asia Pacific market is expected to grow at a lucrative growth rate owing to factors such as growing population, economic development in countries such as India and China support the market growth.

The major players operating in the surgical devices market include Roche, Novartis, Celgene, Bristol Squibb, Lily, Takeda, Astra Zeneca, Merck and co and Amgen among other significant players worldwide. Amgen’s market research analyst predicts that the global surgical market will grow at a CAGR of more than 10% by 2020.

Fig: Incline in Business strategy

An increasing aging population is also resulting in more people suffering from cancer. It is estimated that in the U.S. and Europe, refractive errors affect more than 30% of the population aged 40 or older. The most common procedure for correcting the cancer is chemotherapy. Breast cancer has become the most common type of cancer in the global population. This indication varies across populations of different regions and ethnicities. It is estimated that 1.45 billion women had cancer in 2010 and it is predicted this number will continue to increase as the world’s population grows. The prevalence of cancer is most common among young adults in South- East Asian countries which is around 80-90% of the population completing high school. Global demand for cancer surgery  is expected to grow at a compounded annual rate of 5.5 percent from 2016 to 2021, with annual procedure volume increasing from 3.8 million to 4.9 million.

Drug procedure demand will increase in several major markets during 2016, including the US, Japan, and some Western European countries. As a result, global cancer therapies  procedures will see slight growth in coming years.

Hence,  drugs will continue to be in existing and emerging markets worldwide that will grow sales to nearly $11.1 billion in 2017-19 —a roughly 6.6% increase from the revised $10.4 billion in sales for 2016.


To Collaborate Scientific Professionals around the World

Conference Date September 17-18, 2018

For Sponsors & Exhibitors

Speaker Opportunity

Past Conference Report

Supported By

Journal of Carcinogenesis & Mutagenesis

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by